163 results about "Immunocompetence" patented technology

The invention discloses bifidobacterium animalis and application thereof in allergic rhinitis products, and belongs to the technical field of microorganisms. The technical problem to be solved is that the existing common allergic rhinitis treatment means cannot meet the requirements of patients on safety, long-acting effect and treatment cycle. The invention provides an animal bifidobacterium subsp. Lactis Def +, and after an effective dose of animal bifidobacterium subsp. Lactis Def + is applied to a subject, the animal bifidobacterium subsp. Lactis Def + is found to be capable of remarkably relieving the allergic rhinitis symptom. Specifically, the symptoms of sneezing, dry nose and rhinocnesmus are reduced; the number of nasal septum mucosa intrinsic layer inflammation infiltration cells and nasal septum mucosa epithelium pathological changes are reduced; the IgA and IgE levels of serum are reduced; the levels of proinflammatory factors IL-4, IL-5 and IL-13 are reduced; the normal spleen index is maintained; the imbalance state of Th1 / Th2 and Th17 / Treg is effectively improved, and the body immunity is improved; a safe and long-acting scheme is provided for allergic rhinitis diseases.

The invention provides application of small peptides in preventing and treating plant diseases and promoting plant growth. The structural formula of the small peptide is shown in the specification. Experimental results show that the small peptide shown in the formula A has the effects of improving the disease resistance of plants and regulating the growth of the plants. The small peptide not only can be used as a plant immune resistance inducer at low concentration to improve the immunocompetence of plants for resisting pathogen invasion, but also can promote plant growth, and has a good application prospect. R1-R2-beta-Ala-Trp-Gly-NH2 Formula A

The invention relates to the field of agricultural products, and particularly discloses a polypeptide for improving plant disease resistance, and the polypeptide is LAND2 small peptide and homologous peptide thereof. The LAND2 small peptide disclosed by the invention is screened and found from an arabidopsis thaliana proteome, and homologous peptides of the LAND2 small peptide are respectively derived from chilies and cucumbers. Tests prove that when the LAND2 small peptide is externally applied to arabidopsis thaliana, the local and systematic resistance of plants to botrytis cinerea can be enhanced, and the LAND2 small peptide has broad-spectrum immunocompetence in chilies and cucumbers. The polypeptide is practically applied to agricultural production, can enhance the disease resistance of plants and improve the yield and quality of the plants, and has practical popularization and application values.

The invention discloses a compound micro-ecological preparation for aquatic products as well as a preparation method and application thereof, and belongs to the technical field of micro-ecological preparations. The microecological preparation disclosed by the invention comprises clostridium butyricum, bacillus licheniformis, enterococcus faecalis and lactobacillus plantarum. The microecological preparation is combined with concentrated cottonseed protein for use, can replace fish meal, is added into feed, can remarkably improve the immunocompetence, oxidation resistance and digestive enzyme activity of animals, and can improve the relative abundance of beneficial bacteria in intestinal tracts, inhibit the growth of pathogenic bacteria and regulate the microecological balance of the intestinal tracts after entering the intestinal tracts of the animals. According to the invention, aerobic bacteria and anaerobic bacteria are cooperatively used, oxygen in the surrounding environment is greatly consumed by bacillus licheniformis and enterococcus faecalis, the proliferation of beneficial bacteria such as clostridium butyricum and lactobacillus plantarum is promoted, and the probiotic effect is fully played.

The invention provides a glycolipid metabolism related gene-based endometrial cancer prognosis prediction model construction method, which comprises the following steps of 1, acquiring data containing gene expression and clinical information, and preprocessing the data; 2, differential expression and prognosis gene screening; 3, constructing a prognosis model; 4, analyzing model gene enrichment; 5, evaluating the immunocompetence of the two GLRG related dangerous groups; and step 6, statistical analysis. According to the technical scheme, more accurate and reliable prognosis evaluation is provided for endometrial cancer by comprehensively analyzing multi-dimensional information such as gene expression, immune characteristics, mutation characteristics and drug sensitivity.

The invention is applicable to the technical field of biological medicines, and provides an application of a pharmaceutical composition in preparation of a medicine for improving immunity, the pharmaceutical composition comprises the following raw materials in percentage by weight: 45-6% of ginsenoside Rh, 2-4% of ginsenoside Rk3, 20-30% of ginsenoside Rg3, 3-15% of ginsenoside Rg513, 18-10% of ginsenoside Rk8, and the balance of ginseng extract, totaling 100%. The pharmaceutical composition provided by the invention can enhance the activity of immune cells, regulate the function of an immune system and realize efficient absorption and utilization so as to comprehensively improve the immunocompetence of a body, strengthen physique and help to resist disease invasion, and meanwhile, the pharmaceutical composition as a traditional Chinese medicine has extremely high stability and no toxic or side effect, and is suitable for people at all stages.

The invention discloses an application of pleurotus eryngii purified polysaccharide in preparation of an intestinal care medicine. The pleurotus eryngii purified polysaccharide component has high immunocompetence, high-activity and high-purity polysaccharide is obtained after ethanol precipitation and organic solvent purification, and the high biological activity of the polysaccharide is reserved; the composition has the biological activity of increasing the production of short-chain fatty acid, reducing the inflammation level, improving the intestinal flora structure, influencing the body metabolism condition and protecting the intestinal barrier. Compared with other components in the pleurotus eryngii polysaccharide extraction process, the polysaccharide component obtained by the preparation method has the highest purity and the strongest biological activity, and can be used for preparing intestinal care medicines.

The invention belongs to the technical field of plant genetic engineering, and particularly relates to application of a biological product for overexpressing an OsARF7 gene to improvement of rice disease resistance, the nucleotide sequence of the OsARF7 gene is shown as SEQ ID NO.1, and the amino acid sequence of the OsARF7 gene is shown as SEQ ID NO.2. According to the invention, an OsARF7 overexpression rice strain is constructed by means of transgenosis. Tests show that the overexpression of the OsARF7 can significantly enhance the immunocompetence of the rice, for example, the expression level of a disease-resistant related gene is improved, active oxygen outbreak is significantly induced, and the resistance of the rice to false smut and bacterial leaf blight is significantly improved. The invention proves that the OsARF7 has a positive regulation effect on rice immunity, can be used for improving the disease resistance of rice, and has important significance for creating disease-resistant rice germplasm resources.

The invention discloses application of a broad-spectrum influenza virus polypeptide vaccine in preparation of a medicine for preventing influenza virus infection and controlling influenza virus reinfection, and belongs to the technical field of biological medicine. The vaccine is designed on the basis of artificially synthesized polypeptide, a polypeptide sequence which is highly conservative and has immunocompetence is screened and optimized aiming at various subtype influenza virus proteins, a broad-spectrum polypeptide vaccine P125-H is constructed, and an Ii-Key technology and an MF59 adjuvant are applied to enhance immune response. The vaccine can effectively induce immune protection against H1N1 and H7N9 influenza A viruses, significantly reduce the virus load, reduce pathological injury to the lung and improve the survival rate. The P125-H vaccine is composed of three optimized polypeptides, has a cross protection effect on various influenza virus subtypes, has the potential of being developed into a broad-spectrum influenza vaccine, and provides a new technical scheme for coping with influenza virus variation and improving vaccine efficacy.

The invention relates to the technical field of bioactive substance preparation, and provides a lentil low-molecular-weight glucan with immunocompetence and a preparation method of the lentil low-molecular-weight glucan with immunocompetence, and the lentil low-molecular-weight glucan with immunocompetence is obtained by separating and purifying lentil. The extraction method comprises the following steps: crushing dried lentils, extracting by adopting a compound enzyme-assisted extraction method, freeze-drying to obtain crude polysaccharide, dissolving the crude polysaccharide with distilled water, performing deproteinization treatment by adopting a sevag method, separating the deproteinized solution through an anion exchange cellulose column, collecting effluent, and treating to obtain freeze-dried powder, and dissolving the freeze-dried powder, purifying, carrying out color development tracking, collecting a polysaccharide solution of a color development positive part, and freeze-drying to obtain the purified polysaccharide. The invention solves the problems in the prior art that deep exploration on the structure-function relationship and immunocompetence of the polysaccharide is lacked, and the development of the polysaccharide as an immunomodulatory functional raw material is limited.

The invention discloses an enzymolysis preparation method of high-immunocompetence bovine coloctrum peptide, active peptide and application thereof, and belongs to the field of biotechnology and functional foods.The enzymolysis preparation method is characterized by comprising the steps that bovine coloctrum is degreased, trehalose is added into obtained supernate, first stirring is conducted, and first mixed liquid is obtained; wherein the supernate comprises whey protein and Ig; adding medium protease into the first mixed solution for hydrolysis to obtain enzymatic hydrolysate; wherein the enzymatic hydrolysate comprises a mixture of bovine colostrum hydrolyzed peptides, the Ig activity retention rate is larger than or equal to 90% through the targeted protection and directional enzymolysis technology, the beta-lactoglobulin peptide with the synergistic immune enhancement effect is obtained, the Ig and small molecule peptides in the product have the synergistic effect, the body immune regulation capacity and the intestinal immune function are remarkably improved, the immunity of the human body is improved, and the immunity of the human body is improved. The method can be widely applied to the fields of infant formulas, postoperative nutrition, functional drinks and the like.

The invention relates to the technical field of molecular markers, in particular to a molecular marker for early identification of immune traits of elephant male semi-fine wool sheep and application of the molecular marker. According to the present invention, the deterministic correlation between the genotype of the 102308292 site on the second chromosome and the immune globulin (IgA, IgG and IgM) level of the male semi-fine wool sheep is found for the first time; by detecting the genotype of the site, the future humoral immunity of the lamb can be predicted in the lamb stage, so that early seed selection is realized. The invention provides a powerful SNP marker for non-diagnostic purpose for disease-resistant breeding of male semi-fine wool sheep.

The invention provides ROS (reactive oxygen species) temperature double-sensitive injectable immunocompetence polyamino acid hydrogel and application thereof. The hydrogel can be independently gelled, the drug loading capacity is high and adjustable, and the hydrogel has temperature response, reactive oxygen species (ROS) response and immunostimulatory activity and can be injected. Through temperature response, the hydrogel is in a solution state under a low-temperature condition and is easy to inject, and the hydrogel can be quickly gelatinized under a body temperature condition to locally form a medicine storage cavern, so that the release time of the medicine is prolonged. Due to ROS response, the hydrogel achieves intelligent response to drug release by responding to a high-active oxygen microenvironment of a tumor site, and selective drug release is achieved. Due to the immunocompetence, the hydrogel can positively respond to a high-active-oxygen local microenvironment of a tumor site, R848 is released to stimulate the activity of host immune cells, and the anti-tumor effect is improved. The hydrogel can be simply and conveniently mixed with other treatment drugs for combined treatment, so that the tumor treatment effect is improved.

The invention belongs to the field of food nutrition and functional factors, and particularly relates to a method for preparing ovotransferrin hydrolysate with high immunocompetence based on an adult gastrointestinal simulated digestion system. According to the method, ovotransferrin is treated through the stomach and intestine of a simulated adult, OVT hydrolysate is prepared, and the OVT hydrolysate contains HTEGSTT, TTSY and / or RTAGWVIPMG. The invention finds that the immunomodulatory activity of OVT is enhanced after gastrointestinal digestion and hydrolysis, the OVT is more easily hydrolyzed in simulated adult digestive juice than in infant digestive juice, and a contrast experiment shows that the nutrition intervention of OVT adult and infant simulated digestion products can promote the generation of short-chain fatty acids such as acetic acid, propionic acid and butyric acid; the swelling injury caused by inflammation to small intestine mucous membrane tissues is effectively relieved, so that the intestinal barrier immune function is obviously improved, and the OIA shows higher intestinal immune activity than the OIB.

The invention provides a tuberculosis mRNA vaccine as well as a preparation method and application thereof. The invention firstly provides an antigen, which comprises the following antigen components: at least one fusion protein or chimeric protein formed by mycobacterium tuberculosis early secretion antigens Ag85A and Ag85B and / or immunocompetence fragments thereof, at least one mycobacterium tuberculosis PE / PPE family antigen Rv1759c (PE-PGRS family protein WAG22) or immunocompetence fragments thereof, and at least one immunocompetence fragment thereof, and at least one mycobacterium tuberculosis latent associated antigen Rv1813c or an immunocompetence fragment thereof; selectively, two or more of these antigens or immunocompetent fragments thereof may form a fusion protein and / or chimeric protein as an antigen component. The mRNA vaccine with multiple antigen components has a more effective effect on prevention of tuberculosis.

The present application relates to a kind of traditional Chinese medicine composition for treating chronic non-bacterial prostatitis and its preparation method and application.The traditional Chinese medicine composition includes bran warm Chinese yam, steamed leucomalus, alisma, cistanche, smilax glabra, sanqi head, fried radix codonopsis, fried white kidney bean and prepared rehmannia, with typical characteristics of homology of medicine and food, patient is easy to tolerate, can be taken long-term;And can improve the immune capacity of organism, kidney and yang, support and consolidate, completely relieve chronic prostatitis symptoms until radical cure.

The invention discloses bacillus subtilis Q16 and application thereof, the strain is preserved in the China Center for Type Culture Collection, and the preservation number is CCTCC NO: M 20252232. According to the invention, the bacillus subtilis Q16 is separated from the body of the large yellow croaker and is added into the feed for the large yellow croaker, so that the growth performance, digestion, oxidation resistance and immunity of the large yellow croaker can be remarkably improved, and the intestinal flora composition structure of the large yellow croaker and the gene expression related to immunity and metabolism are changed.

The invention relates to the technical field of biomedicine, in particular to an immunoregulation chiral material as well as a preparation method and application thereof, and the immunoregulation chiral material is formed by self-assembly of an immune active component and a delivery carrier. The immunocompetence component is selected from chiral peptide modified distearoyl phosphatidyl ethanolamine-polyethylene glycol, and the chiral peptide is formed by connecting 6-10 D-alanine monomers through amido bonds. The material can realize accurate targeting on target cells by virtue of specific three-dimensional recognition of chiral peptides and immune cell surface receptors, and reduces non-specific action on normal tissues; a delivery carrier represented by lipid nanoparticles can effectively protect chiral peptides from in-vivo enzymolysis and improve the cycling stability of the chiral peptides, and natural carriers such as exosomes can enhance the biocompatibility and tissue penetrability of the material, so that a new strategy is provided for immunotherapy of diseases such as tumors and the like; the compound is expected to be applied to clinical treatment as a novel immunotherapy drug.

The invention discloses flammulina velutipes polysaccharide nano-liposome as well as a preparation method and application thereof, and belongs to the technical field of biological functional materials. The preparation method specifically comprises the following steps: (1) sequentially performing hot water extraction, deproteinization, alcohol precipitation, dialysis and freeze-drying on flammulina velutipes raw material powder; (2) dissolving in a phosphoric acid buffer solution; (3) mixing and dissolving phospholipid, cationic lipid and a membrane regulator in an organic solvent; (4) mixing and ultrasonic treatment; and (5) carrying out reduced-pressure rotary evaporation, hydration with a phosphate buffer solution, ultrasonic treatment and extrusion. According to the flammulina velutipes polysaccharide nano-liposome and the preparation method thereof, cholesterol is replaced by phytosterol ester to prepare the flammulina velutipes polysaccharide nano-liposome, flammulina velutipes polysaccharide (FVP) is encapsulated in a water core in the liposome, the safety is higher, and the encapsulation efficiency, the storage stability and the immunocompetence of a system are improved. In-vitro experiments prove that the phytosterol ester lipidosome has the effect of promoting macrophage proliferation and nitric oxide generation, and the effect is obviously better than that of the traditional cholesterol lipidosome under the same condition.

The application discloses CpG-containing oligodeoxynucleotide (ODN) with the function of regulating the body's immune capacity and application thereof. The oligodeoxynucleotide in the application is different from the design concept of traditional A-type CpG ODN in sequence and structure, embodies the complex drug-making rule and overcomes the problem of traditional A-type CPG in drug-making. The oligodeoxynucleotide has excellent activity of regulating the body's immune function in vitro and in vivo, can stimulate the production of I, II and III type interferons, regulates the Th1 type immune response, and inhibits the Th2 type and Th17 type inflammatory response. Therefore, the oligodeoxynucleotide can prevent and treat allergic diseases caused by Th2 type immune response, including allergic rhinitis, atopic dermatitis, asthma, chronic obstructive pulmonary disease, eosinophil and Th17 related diseases, can prevent and treat the infection and spread of respiratory or non-respiratory pathogenic microorganisms including viruses, bacteria, fungi and parasites, can improve the immune level of the elderly and immunodeficient population, can convert "cold tumor" into "hot tumor", improve the effect of cancer immunotherapy, can prevent and treat central nervous system diseases related to immune dysfunction such as Alzheimer's disease, and can be applied to other diseases related to immune dysfunction.

This invention provides an oyster peptide and its application in enhancing immunity. The oyster peptide has a novel amino acid structure. The oyster peptide can enhance the activity of immune cells, promote the proliferation of immune cells, promote the development and maturation of immune organs, regulate the in vivo immune environment, promote the secretion of immunoglobulins, and improve humoral immunity.

The invention relates to the technical field of traditional Chinese medicine composition processing, in particular to a compound traditional Chinese medicine composition for improving immunity of poultry and a preparation method of the composition. Aiming at the physiological characteristics of short digestive tract and short food absorption time of the poultry, a basic formula with qi tonifying as a main part and digestion promoting as an assistant part is developed; a new composition is developed by optimizing a self-created basic prescription through technical means such as flavoring, odor reduction and substitution, so that the immune function is remarkably improved, the double effects of effectively reducing the standard deviation of chicken serum IgG and reducing the dispersion degree of data in a group are achieved, the overall improvement of group immunity is achieved, the immune effect of vaccines can be enhanced, and the application prospect is wide. Meanwhile, the dosage of the improved prescription is reduced by 33.3% compared with that of the basic prescription, the medication cost is reduced, in addition, by optimizing the polysaccharide water extraction process, the polysaccharide alcohol extraction process is effectively replaced, the problems that an alcohol extraction method is large in pollution, expensive in equipment and the like are solved, and the application and popularization capacity of the prescription is effectively improved.

The invention relates to the field of immune assessment, in particular to an end-stage nephropathy dialysis patient immune assessment method, which comprises the following steps: preparing a database for storing assessment scores of various parameters; preparing a convolutional neural network, and collecting immune intensity change data before and after dialysis of a patient population as a training library; immune intensity change data before and after dialysis under experimental conditions are obtained under laboratory conditions, the data under the experimental conditions are input into a convolutional neural network, and the convolutional neural network is used for training according to a preset mixing proportion rule and outputting a dialysis cause compensation function; data such as demographic characteristics, basic diseases, representative immune activation state data, representative immune senescence state data and dialysis frequency of a patient are collected, a total score is calculated based on a database and a dialysis cause compensation function, and the immunocompetence of the patient is evaluated. By adopting the method, the immunocompetence fluctuation caused by imperfect biocompatibility of the dialysis membrane can be compensated in immune assessment.

The invention relates to a mycelium extracted from ganoderma lucidum and a preparation method of a culture medium of the mycelium, belongs to the technical field of mycelium extraction, and aims to solve the problems that in the prior art, ganoderma lucidum mycelia grow slowly and are prone to pollution, the content of effective components is unstable, and molecular identification is difficult. The invention provides the solid culture medium prepared from the saussurea involucrata purple yellow extract, the extract is formed by combining effective components of saussurea involucrata and sodium alginate, the growth rate and metabolism efficiency of ganoderma lucidum hyphae can be improved, active substances such as polysaccharides and triterpenes are effectively enriched, and the yield of the ganoderma lucidum hyphae is increased. Meanwhile, the stress resistance and the survival rate of the mycelium under the stress conditions of oxidative stress, pathogen invasion and the like are enhanced, the pollution risk in the culture process is reduced, the biosynthesis efficiency and the extracellular secretion level of key secondary metabolites are improved, the immunocompetence and the bioavailability of the product are further improved, and the production cost is reduced. And a stable and reliable technical support is provided for large-scale and high-quality production of ganoderma lucidum.

The invention discloses Pseudomonas mendogensis Z3-4 capable of inducing tobacco bacterial wilt immunity and application of the Pseudomonas mendogensis Z3-4. The Pseudomonas mendogensis Z3-4 is preserved in China General Microbiological Culture Collection Center (CGMCC), the preservation address is Beijing, the preservation center number is CGMCC No.35660, the preservation date is August 18, 2025, and the Pseudomonas mendogensis Z3-4 is classified and named as Pseudomonas mendogensis. The strain Z3-4 is an efficient tobacco root colonization bacterium, and can significantly induce the immunocompetence of tobacco to bacterial wilt. The strain Z3-4 is used as a tobacco bacterial wilt resistant vaccine, is applied by adopting a root irrigation method, can effectively prevent and treat tobacco bacterial wilt, and has a wide application prospect.

The invention belongs to the technical field of gene engineering, and particularly relates to recombinant lactobacillus for expressing clostridium perfringens multiple antigens of targeted dendritic cells as well as a construction method and application of the recombinant lactobacillus. The recombinant lactobacillus contains an expression vector for expressing a fusion gene; the fusion gene comprises sequences for coding and expressing a PgsA '-fimA fusion protein, a LysM-Fba fusion protein, an LP1261-NetB fusion protein, a phi54 targeting element and a Pas escape element; a sequence for coding the PgsA '-fimA fusion protein is shown as SEQ ID NO: 1, a sequence for coding the LysM-Fba fusion protein is shown as SEQ ID NO: 2, and a sequence for coding the LP1261-NetB fusion protein is shown as SEQ ID NO: 3. When the recombinant lactobacillus is used for immunizing animals, mucosal immunity, cellular immunity and humoral immunity reactions can be induced, the immunocompetence of organisms can be comprehensively enhanced, and the recombinant lactobacillus can be used for preparing oral vaccines for prevention and control of chicken necrotic enteritis.

Disclosed are methods for determining the immunological status of the adaptive immune system of a subject by identifying and quantifying rearranged DNA (and / or subsequently transcribed RNA) sequences encoding T cell receptor (TCR) and / or immunoglobulin (IG) polypeptides, in a lymphoid DNA-containing sample from the subject. TCR and / or IG sequence diversity and sequence distribution permit immunocompetence and immune repertoire assessment and reflect the degree of T cell or B cell clonality and clonal expansion in the sample. Methods for stratifying patient populations on the basis of immunocompetence including likelihood of responding to immunotherapy are also described.

The present invention provides a clinically applicable method of stem cell transplantation that facilitates engraftment and reconstitutes immunocompetence of the recipient without requiring radiotherapy or chemotherapy, and without development of GVHD or graft rejection. Aspects of the present invention are based on the discovery that the depletion of the endogenous stem cell niche facilitates efficient engraftment of stem cells into that niche. In particular, the present invention combines the use of selective ablation of endogenous stem cells with a combination of antibodies specific for CD117, and agents that modulate immunoregulatory signaling pathways, e.g. agonists of immune costimulatory molecules, in combination with the administration to the recipient of exogenous stem cells, resulting in efficient, long-term engraftment, even in immunocompetent recipients.

The application provides a lactic acid bacteria expressing an African swine fever virus fusion antigen and an application thereof. The lactic acid bacteria are integrated with a fusion gene, the fusion gene comprising a gene encoding an OprI protein and at least one gene selected from genes encoding a PP62 protein, an MGF505-3R protein, an EP364R protein, a K145R protein and a DP96R protein, and a starting strain of the lactic acid bacteria is Lactobacillus plantarum. Using the lactic acid bacteria to immunize animals can induce mucosal immunity, cellular immunity and humoral immunity responses, and comprehensively enhance the immune capacity of the body, and the lactic acid bacteria can be used for preparing an oral vaccine for the prevention and control of African swine fever.

The application provides an antigen nanoparticle and a preparation method and vaccine preparation application thereof, and relates to the technical field of biotechnology.The antigen nanoparticle provided by the application comprises an antigen and poly( maleic anhydride-ALT-1-octadecene) grafted with polyethylene glycol, the antigen nanoparticle has good stability and high immunocompetence, and can be used for the preparation of a vaccine.The preparation method of the antigen nanoparticle provided by the application is convenient to operate, parameters are controllable, reproducibility is good, and the reaction is carried out in a water environment, the condition is mild, and the influence on the structure of the antigen is small.The vaccine provided by the application comprises the antigen nanoparticle and an adjuvant, and the inventor has found that the antigen nanoparticle and the adjuvant have a synergistic effect, and the combination of the two can further improve the immunization effect of the vaccine.